• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

右丙亚胺(ICRF - 187)通过防止线粒体损伤来保护心肌细胞免受阿霉素的伤害。

Dexrazoxane (ICRF-187) protects cardiac myocytes against doxorubicin by preventing damage to mitochondria.

作者信息

Hasinoff Brian B, Schnabl Kareena L, Marusak Rosemary A, Patel Daywin, Huebner Erwin

机构信息

Faculty of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada R3T 2N2.

出版信息

Cardiovasc Toxicol. 2003;3(2):89-99. doi: 10.1385/ct:3:2:89.

DOI:10.1385/ct:3:2:89
PMID:14501028
Abstract

The clinically approved antioxidant cardioprotective agent dexrazoxane (ICRF-187) was examined for its ability to protect neonatal rat cardiac myocytes from doxorubicin-induced damage. Doxorubicin is thought to induce oxidative stress on the heart muscle, both through reductive activation to its semiquinone form, and by the production of hydroxyl radicals mediated by its complex with iron. Hydrolyzed dexrazoxane metabolites prevent site-specific iron-based oxygen radical damage by displacing iron from doxorubicin and chelating free and loosely bound iron. The mitochondrial stain MitoTracker Green FM and doxorubicin were shown by epifluorescence microscopy to accumulate in the myocyte mitochondria. An epifluorescence microscopic image analysis method to measure mitochondrial damage was developed using the mitochondrial membrane potential sensing ratiometric dye JC-1. This method was used to show that dexrazoxane protected against doxorubicin-induced depolarization of the myocyte mitochondrial membrane. Dexrazoxane also attenuated doxorubicin-induced oxidation of intracellular dichlorofluorescin. Annexin V-FITC/propidium iodide staining of myocytes was used to demonstrate that, depending on the concentration, doxorubicin caused both apoptotic and necrotic damage. These results suggest that doxorubicin may be cardiotoxic by damaging the mitochondria and dexrazoxane may be protective by preventing iron-based oxidative damage.

摘要

对临床批准的抗氧化心脏保护剂右丙亚胺(ICRF-187)保护新生大鼠心肌细胞免受阿霉素诱导损伤的能力进行了研究。阿霉素被认为会通过还原激活为其半醌形式以及通过与铁形成复合物介导产生羟基自由基,从而对心肌诱导氧化应激。水解的右丙亚胺代谢产物通过将铁从阿霉素中置换出来并螯合游离和松散结合的铁,防止位点特异性的基于铁的氧自由基损伤。通过落射荧光显微镜观察发现,线粒体染色剂MitoTracker Green FM和阿霉素会在心肌细胞线粒体中积累。利用线粒体膜电位传感比率染料JC-1开发了一种落射荧光显微镜图像分析方法来测量线粒体损伤。该方法用于表明右丙亚胺可防止阿霉素诱导的心肌细胞线粒体膜去极化。右丙亚胺还减弱了阿霉素诱导的细胞内二氯荧光素氧化。利用膜联蛋白V-异硫氰酸荧光素/碘化丙啶对心肌细胞进行染色,以证明根据浓度不同,阿霉素会导致凋亡性损伤和坏死性损伤。这些结果表明,阿霉素可能通过损伤线粒体而具有心脏毒性,而右丙亚胺可能通过防止基于铁的氧化损伤而具有保护作用。

相似文献

1
Dexrazoxane (ICRF-187) protects cardiac myocytes against doxorubicin by preventing damage to mitochondria.右丙亚胺(ICRF - 187)通过防止线粒体损伤来保护心肌细胞免受阿霉素的伤害。
Cardiovasc Toxicol. 2003;3(2):89-99. doi: 10.1385/ct:3:2:89.
2
Deferiprone protects against doxorubicin-induced myocyte cytotoxicity.去铁酮可防止阿霉素诱导的心肌细胞毒性。
Free Radic Biol Med. 2002 Jul 15;33(2):266-75. doi: 10.1016/s0891-5849(02)00873-0.
3
The metabolites of the cardioprotective drug dexrazoxane do not protect myocytes from doxorubicin-induced cytotoxicity.心脏保护药物右丙亚胺的代谢产物不能保护心肌细胞免受阿霉素诱导的细胞毒性作用。
Mol Pharmacol. 2003 Sep;64(3):670-8. doi: 10.1124/mol.64.3.670.
4
Dexrazoxane (ICRF-187) protects cardiac myocytes against hypoxia-reoxygenation damage.
Cardiovasc Toxicol. 2002;2(2):111-8. doi: 10.1385/ct:2:2:111.
5
The iron chelator Dp44mT does not protect myocytes against doxorubicin.铁螯合剂Dp44mT不能保护心肌细胞免受阿霉素的损伤。
J Inorg Biochem. 2009 Jul;103(7):1093-101. doi: 10.1016/j.jinorgbio.2009.05.007. Epub 2009 May 21.
6
Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy.评估拓扑异构酶II失活的双二氧哌嗪ICRF-161作为阿霉素诱导的心肌病保护剂的作用。
Toxicology. 2009 Jan 8;255(1-2):72-9. doi: 10.1016/j.tox.2008.10.011. Epub 2008 Oct 25.
7
The doxorubicin cardioprotective agent dexrazoxane (ICRF-187) induces endopolyploidy in rat neonatal myocytes through inhibition of DNA topoisomerase II.
Anticancer Drugs. 2002 Mar;13(3):255-8. doi: 10.1097/00001813-200203000-00007.
8
The oral iron chelator ICL670A (deferasirox) does not protect myocytes against doxorubicin.口服铁螯合剂ICL670A(地拉罗司)不能保护心肌细胞免受阿霉素的损伤。
Free Radic Biol Med. 2003 Dec 1;35(11):1469-79. doi: 10.1016/j.freeradbiomed.2003.08.005.
9
Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats.右丙亚胺可预防阿霉素诱导的大鼠长期心脏毒性,并保护心肌线粒体免受遗传和功能损伤。
Br J Pharmacol. 2007 Jul;151(6):771-8. doi: 10.1038/sj.bjp.0707294. Epub 2007 May 21.
10
A QSAR study that compares the ability of bisdioxopiperazine analogs of the doxorubicin cardioprotective agent dexrazoxane (ICRF-187) to protect myocytes with DNA topoisomerase II inhibition.一种比较阿霉素心脏保护剂右雷佐生(ICRF-187)双二氧哌嗪类似物与 DNA 拓扑异构酶 II 抑制作用保护心肌细胞能力的定量构效关系研究。
Toxicol Appl Pharmacol. 2020 Jul 15;399:115038. doi: 10.1016/j.taap.2020.115038. Epub 2020 May 15.

引用本文的文献

1
Histidine triad nucleotide-binding protein 2 attenuates doxorubicin-induced cardiotoxicity through restoring lysosomal function and promoting autophagy in mice.组氨酸三联体核苷酸结合蛋白2通过恢复溶酶体功能和促进小鼠自噬减轻阿霉素诱导的心脏毒性。
MedComm (2020). 2025 Feb 17;6(3):e70075. doi: 10.1002/mco2.70075. eCollection 2025 Mar.
2
to clinical translation of combinatorial effects of doxorubicin and dexrazoxane in breast cancer: a mechanism-based pharmacokinetic/pharmacodynamic modeling approach.多柔比星与右丙亚胺联合作用于乳腺癌的临床转化:基于机制的药代动力学/药效学建模方法
Front Pharmacol. 2023 Oct 19;14:1239141. doi: 10.3389/fphar.2023.1239141. eCollection 2023.
3
In vitro to clinical translational pharmacokinetic/pharmacodynamic modeling of doxorubicin (DOX) and dexrazoxane (DEX) interactions: Safety assessment and optimization.
多柔比星(DOX)和右雷佐生(DEX)相互作用的体外至临床转化药代动力学/药效学模型:安全性评估和优化。
Sci Rep. 2023 Feb 22;13(1):3100. doi: 10.1038/s41598-023-29964-4.
4
Early Doxorubicin Myocardial Injury: Inflammatory, Oxidative Stress, and Apoptotic Role of Galectin-3.早期多柔比星心肌损伤:半乳糖凝集素-3 的炎症、氧化应激和凋亡作用。
Int J Mol Sci. 2022 Oct 18;23(20):12479. doi: 10.3390/ijms232012479.
5
Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity.线粒体靶向治疗多柔比星所致心脏毒性。
Int J Mol Sci. 2022 Feb 9;23(3):1912. doi: 10.3390/ijms23031912.
6
Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity.揭开二甲双胍、AMPK与阿霉素心脏毒性之间的关系
Front Cardiovasc Med. 2022 Jan 24;9:839644. doi: 10.3389/fcvm.2022.839644. eCollection 2022.
7
Anticancer potential of (-)-epicatechin in a triple-negative mammary gland model.(-)-表儿茶素在三阴性乳腺模型中的抗癌潜力。
J Pharm Pharmacol. 2021 Dec 7;73(12):1675-1682. doi: 10.1093/jpp/rgab133.
8
Chinese Herbal Medicine, Guilu Erxian Glue, as Alternative Medicine for Adverse Side Effects of Chemotherapy in Doxorubicin-Treated Cell and Mouse Models.中药,龟鹿二仙胶,作为阿霉素处理的细胞和小鼠模型中化疗副作用的替代药物。
Evid Based Complement Alternat Med. 2021 Apr 5;2021:5548968. doi: 10.1155/2021/5548968. eCollection 2021.
9
Dysregulation of Catalase by a Sulphamoylated Estradiol Analogue Culminates in Antimitotic Activity and Cell Death Induction in Breast Cancer Cell Lines.磺酰化雌二醇类似物对过氧化氢酶的调节失调导致乳腺癌细胞系的抗有丝分裂活性和细胞死亡诱导。
Molecules. 2021 Jan 25;26(3):622. doi: 10.3390/molecules26030622.
10
Multiscale and Translational Quantitative Systems Toxicology, Pharmacokinetic-Toxicodynamic Modeling Analysis for Assessment of Doxorubicin-Induced Cardiotoxicity.多尺度与转化定量系统毒理学:用于评估多柔比星心脏毒性的药代动力学-药效动力学建模分析。
AAPS J. 2021 Jan 6;23(1):18. doi: 10.1208/s12248-020-00542-0.